GENETICS OFNEUROPATHOGENIC SIV INFECTION

神经病原性 SIV 感染的遗传学

基本信息

  • 批准号:
    7715711
  • 负责人:
  • 金额:
    $ 9.52万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2008
  • 资助国家:
    美国
  • 起止时间:
    2008-05-01 至 2009-04-30
  • 项目状态:
    已结题

项目摘要

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. AIDS dementia is a progressive neurological disease that affects a significant portion of HIV-infected persons. A major gap in knowledge concerns the role of viral sequences in the induction of neurologic disease. We have identified a simian immunodeficiency virus (SIV) isolate, termed SIVsmmFGb, derived from a sooty mangabey, which is highly neuropathogenic in pigtailed macaques. The central hypothesis is that there is genetic selection and evolution of SIV that occurs in the CNS, separate from that in the lymphoid system, which is directly related to the development of neurologic disease. Specifically, 1) genotypic selection occurs after virus enters the CNS; 2) viral evolution is the CNS is distinct from the lymphoid tissue; 3) genotypic compartmentalization occurs in the CNS and is related to the development of neurologic disease; and 4) along with genotypic evolution of SIV in the CNS, phenotypic evolution also occurs, which facilitates growth in the CNS and also facilitates development of neurologic disease. To address these hypotheses, we compared the selection and evolution of SIV genotypes in the CNS and the lymphoid system at immediate early (7 days) and early times (2 months) after infection. Current data suggests that while the initial invasion of the CNS by virus is not limited to specific sequences, there is an initial compartmentalization of sequences within the CNS and the lymphoid system. We have shown that a unique molecular clone of SIV derived from the brain of a SIVsmmFGb-infected macaque can only infect macrophages. This virus has been inoculated into two pigtailed macaques to investigate the effects of such an unusual virus. To date, the animals have shown no signs of disease development and have not corrected the mutation responsible for the unusual characteristics of the virus.
这个子项目是许多研究子项目中利用 资源由NIH/NCRR资助的中心拨款提供。子项目和 调查员(PI)可能从NIH的另一个来源获得了主要资金, 并因此可以在其他清晰的条目中表示。列出的机构是 该中心不一定是调查人员的机构。 艾滋病痴呆症是一种进行性神经系统疾病,影响到很大一部分艾滋病毒感染者。关于病毒序列在诱发神经系统疾病中的作用,知识上的一个主要差距。我们已经鉴定出一种猴免疫缺陷病毒(SIV)分离株,命名为SIVsmmFGb,它来自于一种在辫尾猕猴中高度神经致病的煤烟曼加比病毒。中心假说是,SIV存在发生在中枢神经系统的遗传选择和进化,与淋巴系统的遗传选择和进化是分开的,这与神经系统疾病的发展直接相关。具体地说,1)病毒进入中枢神经系统后发生基因选择;2)病毒进化是指中枢神经系统与淋巴组织不同;3)中枢神经系统发生基因区隔,与神经系统疾病的发生有关;4)随着SIV在中枢神经系统的基因进化,表型进化也会发生,这有利于中枢神经系统的生长,也有助于神经系统疾病的发展。为了解决这些假设,我们比较了感染后即刻早期(7天)和早期(2个月)中枢和淋巴系统中SIV基因型的选择和进化。目前的数据表明,虽然病毒对中枢神经系统的初始入侵并不局限于特定的序列,但在中枢神经系统和淋巴系统内存在着序列的初始划分。我们已经证明了来自SIVsmmFGb感染猕猴大脑的SIV的一个独特的分子克隆只能感染巨噬细胞。这种病毒已经接种到两只辫子猕猴体内,以研究这种不寻常的病毒的影响。到目前为止,这些动物还没有表现出疾病发展的迹象,也没有纠正导致病毒异常特征的突变。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

FRANCIS J NOVEMBRE其他文献

FRANCIS J NOVEMBRE的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('FRANCIS J NOVEMBRE', 18)}}的其他基金

TOPICAL MICROBICIDE DRUG COMBINATIONS FOR THE PREVENTION OF SHIV
用于预防 SHIV 的外用杀菌剂药物组合
  • 批准号:
    8357460
  • 财政年份:
    2011
  • 资助金额:
    $ 9.52万
  • 项目类别:
TOPICAL MICROBICIDE DRUG COMBINATIONS FOR THE PREVENTION OF SHIV
用于预防 SHIV 的外用杀菌剂药物组合
  • 批准号:
    8172412
  • 财政年份:
    2010
  • 资助金额:
    $ 9.52万
  • 项目类别:
TOPICAL MICROBICIDE DRUG COMBINATIONS FOR THE PREVENTION OF SHIV
用于预防 SHIV 的外用杀菌剂药物组合
  • 批准号:
    7958237
  • 财政年份:
    2009
  • 资助金额:
    $ 9.52万
  • 项目类别:
GENETICS OFNEUROPATHOGENIC SIV INFECTION
神经病原性 SIV 感染的遗传学
  • 批准号:
    7958143
  • 财政年份:
    2009
  • 资助金额:
    $ 9.52万
  • 项目类别:
TOPICAL MICROBICIDE DRUG COMBINATIONS FOR THE PREVENTION OF SHIV
用于预防 SHIV 的外用杀菌剂药物组合
  • 批准号:
    7715839
  • 财政年份:
    2008
  • 资助金额:
    $ 9.52万
  • 项目类别:
GENETICS OFNEUROPATHOGENIC SIV INFECTION
神经病原性 SIV 感染的遗传学
  • 批准号:
    7562557
  • 财政年份:
    2007
  • 资助金额:
    $ 9.52万
  • 项目类别:
GENETICS OFNEUROPATHOGENIC SIV INFECTION
神经病原性 SIV 感染的遗传学
  • 批准号:
    7349209
  • 财政年份:
    2006
  • 资助金额:
    $ 9.52万
  • 项目类别:
HIV ACTIVATION IN ALCOHOL-AIDED G VAGINALIS VIRULENCE
酒精辅助的阴道 G 病毒毒力中的 HIV 激活
  • 批准号:
    7349263
  • 财政年份:
    2006
  • 资助金额:
    $ 9.52万
  • 项目类别:
EVALUATION OF A CANDIDATE MICROBICIDE ON HIV-1
对 HIV-1 候选杀菌剂的评估
  • 批准号:
    7165963
  • 财政年份:
    2005
  • 资助金额:
    $ 9.52万
  • 项目类别:
GENETICS OFNEUROPATHOGENIC SIV INFECTION
神经病原性 SIV 感染的遗传学
  • 批准号:
    7165959
  • 财政年份:
    2005
  • 资助金额:
    $ 9.52万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 9.52万
  • 项目类别:
    Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 9.52万
  • 项目类别:
    Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 9.52万
  • 项目类别:
    Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 9.52万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 9.52万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 9.52万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 9.52万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 9.52万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 9.52万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 9.52万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了